Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial
- Author
- GREENSPAN, Susan L; EMKEY, Ronald D; MULLOY, Anthony L; HEYDEN, Norman; MEI WU; KAUR, Amarjot; LOMBARDI, Antonio; BONE, Henry G; WEISS, Stuart R; BELL, Norman H; DOWNS, Robert W; MCKEEVER, Clark; MILLER, Sam S; DAVIDSON, Michael; BOLOGNESE, Michael A
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Bethesda Health Research, Bethesda, Maryland, United States
Chicago Center for Clinical Research, Chicago, Illinois, United States
Medical College of Georgia, Augusta, Georgia, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Merck and Co., Inc., Rahway, New Jersey, United States
Michigan Bone and Mineral Clinic, Detroit, Michigan, United States
Radiant Research Reading, Wyomissing, Pennsylvania, United States
Research for Health, Houston, United States
SAM Clinical Research Center, San Antonio, Texas, United States
San Diego Endocrinology and Medical Clinic, San Diego, California, United States
University of Pittsburgh, Pittsburgh, United States
Virginia Commonwealth University, Richmond, Virginia, United States - Source
Annals of internal medicine. 2002, Vol 137, Num 11, pp 875-883, 9 p ; ref : 21 ref
- CODEN
- AIMEAS
- ISSN
- 0003-4819
- Scientific domain
- General medicine general surgery
- Publisher
- American College of Physicians, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Acide alendronique Arrêt traitement Association médicamenteuse Bisphosphonates Chimiothérapie Composé conjugué Diphosphonique acide dérivé Femelle Homme Hormone stéroïde sexuelle Oestrogène Os Ostéoporose Perte Postménopause Traitement substitutif Traitement Ostéopathie Système ostéoarticulaire pathologie
- Keyword (en)
- Alendronic acid Treatment withdrawal Drug combination Bisphosphonates Chemotherapy Conjugated compound Diphosphonic acid derivatives Female Human Sex steroid hormone Estrogen Bone Osteoporosis Loss Postmenopause Replacement therapy Treatment Bone disease Diseases of the osteoarticular system
- Keyword (es)
- Acido alendrónico Paro tratamiento Asociación medicamentosa Bisfosfonatos Quimioterapia Compuesto conjugado Difosfonico ácido derivado Hembra Hombre Hormona esteroide sexual Estrógeno Hueso Osteoporosis Pérdida Postmenopausia Tratamiento sustitutivo Tratamiento Osteopatía Sistema osteoarticular patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02O Hormones. Endocrine system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 14386308
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.7326/0003-4819-137-11-200212030-00008 
https://dx.doi.org/10.7326/0003-4819-137-11-200212030-00008
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"883\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"EMKEY, Ronald D\";i:1;s:17:\"MULLOY, Anthony L\";i:2;s:14:\"HEYDEN, Norman\";i:3;s:6:\"MEI WU\";i:4;s:13:\"KAUR, Amarjot\";i:5;s:17:\"LOMBARDI, Antonio\";i:6;s:13:\"BONE, Henry G\";i:7;s:15:\"WEISS, Stuart R\";i:8;s:14:\"BELL, Norman H\";i:9;s:15:\"DOWNS, Robert W\";i:10;s:15:\"MCKEEVER, Clark\";i:11;s:13:\"MILLER, Sam S\";i:12;s:17:\"DAVIDSON, Michael\";i:13;s:20:\"BOLOGNESE, Michael A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"883\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"EMKEY, Ronald D\";i:1;s:17:\"MULLOY, Anthony L\";i:2;s:14:\"HEYDEN, Norman\";i:3;s:6:\"MEI WU\";i:4;s:13:\"KAUR, Amarjot\";i:5;s:17:\"LOMBARDI, Antonio\";i:6;s:13:\"BONE, Henry G\";i:7;s:15:\"WEISS, Stuart R\";i:8;s:14:\"BELL, Norman H\";i:9;s:15:\"DOWNS, Robert W\";i:10;s:15:\"MCKEEVER, Clark\";i:11;s:13:\"MILLER, Sam S\";i:12;s:17:\"DAVIDSON, Michael\";i:13;s:20:\"BOLOGNESE, Michael A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"883\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"EMKEY, Ronald D\";i:1;s:17:\"MULLOY, Anthony L\";i:2;s:14:\"HEYDEN, Norman\";i:3;s:6:\"MEI WU\";i:4;s:13:\"KAUR, Amarjot\";i:5;s:17:\"LOMBARDI, Antonio\";i:6;s:13:\"BONE, Henry G\";i:7;s:15:\"WEISS, Stuart R\";i:8;s:14:\"BELL, Norman H\";i:9;s:15:\"DOWNS, Robert W\";i:10;s:15:\"MCKEEVER, Clark\";i:11;s:13:\"MILLER, Sam S\";i:12;s:17:\"DAVIDSON, Michael\";i:13;s:20:\"BOLOGNESE, Michael A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"883\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"EMKEY, Ronald D\";i:1;s:17:\"MULLOY, Anthony L\";i:2;s:14:\"HEYDEN, Norman\";i:3;s:6:\"MEI WU\";i:4;s:13:\"KAUR, Amarjot\";i:5;s:17:\"LOMBARDI, Antonio\";i:6;s:13:\"BONE, Henry G\";i:7;s:15:\"WEISS, Stuart R\";i:8;s:14:\"BELL, Norman H\";i:9;s:15:\"DOWNS, Robert W\";i:10;s:15:\"MCKEEVER, Clark\";i:11;s:13:\"MILLER, Sam S\";i:12;s:17:\"DAVIDSON, Michael\";i:13;s:20:\"BOLOGNESE, Michael A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-137-11-200212030-00008\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"883\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"EMKEY, Ronald D\";i:1;s:17:\"MULLOY, Anthony L\";i:2;s:14:\"HEYDEN, Norman\";i:3;s:6:\"MEI WU\";i:4;s:13:\"KAUR, Amarjot\";i:5;s:17:\"LOMBARDI, Antonio\";i:6;s:13:\"BONE, Henry G\";i:7;s:15:\"WEISS, Stuart R\";i:8;s:14:\"BELL, Norman H\";i:9;s:15:\"DOWNS, Robert W\";i:10;s:15:\"MCKEEVER, Clark\";i:11;s:13:\"MILLER, Sam S\";i:12;s:17:\"DAVIDSON, Michael\";i:13;s:20:\"BOLOGNESE, Michael A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:226:\"Significant differential effects of alendronate, estrogen, or Combination therapy on the rate of Bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
